If you're feeling distracted as an investor, you're not alone.

And we're going to see if we can help with that.

Motley Fool Money starts now.

I'm Chris Hill and I'm joined by Motley Fool's Senior Analyst, Jason Moser.

Happy August.

Man, August already.

Happy August indeed.

That is moving by fast, isn't it?

It certainly is.

We are actually going to revisit a couple of stocks that have been talked about on this

show recently.

And I want to start with outset medical because this was a stock on your radar a couple

of weeks ago on the radio show.

And for those unfamiliar, what is the 22nd version of what outset medical does?

Yeah, I mean, outset medical is in the business of dialysis.

They have a machine that they've developed called the Tableau.

It's a dialysis console and ultimately dialysis historically has been seen as an expensive

cumbersome, tough to schedule process, right?

There's a lot to it and it's not terribly convenient, but it is a necessary treatment

for a large population of individuals out there today.

And so outset, set out to develop a dialysis machine that ultimately utilizes wireless

technology in order to help make the process easier, more affordable and more convenient.

...